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The Ethical Principle of Vulnerability and the Case Against
Human Organ Trafficking
Peter A. DePergola II
University of Massachusetts Medical School
College of Our Lady of the Elms
ABSTRACT
An increasingly blurred understanding of the ethical significance of global "transplant
transactions" - a curious combination of altruism and commerce, consent and coercion,
gifts and theft, science and sorcery, care and human sacrifice - suggest a critical need to
revisit the fundamental moral normlessness of the trafficking enterprise. This essay
grounds its arguments in two, straightforward premises: (i) the ethical principle of respect
for human vulnerability is an indispensable measure of the licitness of most, if not all,
moral actions; and (ii) human organ trafficking violates the ethical principle of respect for
human vulnerability. Drawing from this syllogism, the aim and proposal of this essay
posits the argument that human organ trafficking cannot, in most, if not all, cases, be
morally justified insofar as it violates the ethical principle of respect for human
vulnerability.
Keywords: Transplantation Ethics, Human Organ Trafficking, Ethical Principle of Vulnerability,
Case Against Organ Trafficking

1. INTRODUCTION
1.1 Overview
The widespread development of transplant capabilities has effected a global
scarcity of transplantable organs.1 Meanwhile, viable organs continue to be cremated and
buried, and many individuals remain legally prohibited from participation in “organ
trading,” the buying and selling of human organs.2 Some scholars contend that
participation in trading is a morally licit means by which to address the widespread
scarcity of organs.3, 4 So long as the exchange is the product of fair opportunity – “fair” in
the sense of an agreeable service provided for a reasonable fee, with no long-term
negative effects – respect for autonomy suggests honoring the decisions of trading
participants. Other scholars maintain that trading organs is an inherently unjustifiable

1. Nancy Scheper-Hughes, “Rotten Trade: Millennial Capitalism, Human Values and Global
Justice in Organs Trafficking,” Journal of Human Rights 2, no. 2 (June 2003): 197.
2. See D. A. Budiani-Saberi and F. L. Delmonico, “Organ Trafficking and Transplant Tourism: A
Commentary on the Global Realities,” American Journal of Transplantation 8 (2008): 925-29; see
especially p. 925.
3. See Benjamin E. Hippen, “In Defense of a Regulated Market in Kidneys from Living
Donors.” Journal of Medicine and Philosophy 30 (2005): 593-626.
4. See Mark J. Cherry, “Embracing the Commodification of Human Organs: Transplantation and
the Freedom to Sell Body Parts,” Saint Louis University Journal of Health Law and Policy 2, vol. 2 (2009):
359-78.

moral action, no matter how benevolent the intended end or how “fair” the process.5, 6, 7
Selling one’s organs is contrary to human dignity inasmuch as it inescapably targets
vulnerable populations and thereby proves impedimentary to the prospective donor’s
capacity to give free, full, and informed consent.8, 9
Human organ trafficking, the enterprise of organ trading and tourism that
explicitly involves the coercion or deception of persons into exploitative, slavery-like
practices,10 is a particularly notorious manifestation of organ trading. Today, trafficking
remains a highly profitable global activity for organized crime,11 and counts for five to
ten percent of kidney transplants performed annually around the world.12, 13 The rise in
global trafficking portrayed in the media features brokers, physicians, and hospitals
engaged in the illegal trading of organs by way of explicit exploitation of poor
populations in under-resourced countries, such as India,14 Pakistan,15, 16, 17 and Turkey,18,
19, 20
in which substandard medical care is normative. Such stories portray the reduction
of once-commendable social acts to clandestine financial offers and incentives – ranging
from $1,000 - $87,000 per organ, and $35,000 - $150,000 per “package deal” – that
coerce donation from the world’s most thoroughly underserved. Moreover, trafficking
5. See Nancy Scheper-Hughes, “The Global Traffic in Human Organs,” Current Anthropology
41, no. 2 (2000):191-224.
6. See Nancy Scheper-Hughes, “The Ends of the Body: Commodity Fetishism and the Global
Traffic in Organs,” SAIS Review, vol. XXII, no. 1 (Winter-Spring 2002): 61-80.
7. See Scheper-Hughes, “Rotten Trade” Journal of Human Rights 2, no. 2 (2003): 197-226.
8. Shaun D. Pattinson, “Bioethics and Human Rights: Organ Trading, Tourism, and Trafficking
within Europe,” Medicine and Law 191 (2008): 1.
9. R. R. Kishore, “Human Organs, Scarcities, and Sale: Morality Revisited,” Journal of Medical
Ethics 31 (2005): 363.
10. Sarah Leevan, “Comparative Treatment of Human Trafficking in the United States and Israel:
Financial Tools to Encourage Victim Rehabilitation and Prevent Trafficking,” Cardozo Public Law, Policy,
and Ethics Journal 773 (Spring 2008): 1.
11. Pattinson, “Bioethics and Human Rights,” 1-8; see especially p. 1.
12. Budiani-Saberi and Delmonico, “Organ Trafficking and Transplant Tourism,” 925-29; see
especially p. 925.
13. See Yosuke Shimazono, “The State of the International Organ Trade: A Provisional Picture
Based on Integration of Available Information,” Bulletin of the World Health Organization 85 (2007): 99562.
14. See Budiani-Saberi and Delmonico, “Organ Trafficking and Transplant Tourism,” 925-29.
15. See Farhat Moazam, “Pakistan and Kidney Trade: Battles Won, Battles to Come,” Medicine,
Health Care and Philosophy (2012): 1-4.
16. See Farhat Mozam, Riffat Moazam Zaman, and Aamir M. Jafarey, “Conversations with
Kidney Vendors in Pakistan: An Ethnographic Study,” The Hastings Center Report 39, no. 3 (2009): 29-44.
17. See Abidul Hasan S. Rizvi, S. Rizvi, Anwar S. A. Naqvi, Naqi M. Zafar, and Ejaz Ahmed,
“Regulated Compensated Donation in Pakistan and Iran,” Current Opinion in Organ Transplantation 14
(2009): 124-28.
18. See Francis L. Delmonico, “The Implications of Istanbul Declaration on Organ Trafficking
and Transplant Tourism,” Current Opinion in Organ Transplantation 14 (2009): 116-19.
19. See A. I. Reed, R. M. Merion, J. P. Roberts, G. B. Klintmalm, M. M. Abecassis, K. M.
Olthoff, and A. N. Langas, “The Declaration of Instanbul: Review and Commentary by the American
Society of Transplant Surgeons Ethics Committee and Executive Committee,” American Journal of
Transplantation 9 (2009): 2466-69.
20. See Rick Luscombe, “The Declaration of Istanbul on Organ Trafficking and Transplant
Tourism,” The CANNIT Journal 20, no. 2 (April-June 2010): 6.

practices, past and present, have failed to provide even the most elemental post-operative
care for donors. As such, trafficking exemplifies a stark violation of human rights,
particularly for those vulnerable groups for whom participation may seem the only way
to realize and secure those fundamental rights.21
Unfortunately, this is just the beginning of a global account, much too long and
winding, of a problem of tremendous domestic and international moral concern. These
“transplant transactions,” as it were – a curious combination of “altruism and commerce;
consent and coercion; gifts and theft; science and sorcery; care and human sacrifice”22 –
suggest a critical need to revisit the fundamental moral illicitness of the trafficking
enterprise. To be sure, the issues of immediate import to the trafficking conversation are
manifold, and any singular analysis of topics, no matter how sweeping, will unavoidably
fall short of adequacy. This essay thus aims to briefly address but three: (i) the principle
of respect for human vulnerability, (ii) the contemporary enterprise of human organ
trafficking, and (iii) the case in favor of a regulated market in organs.
1.2 Analytical Method
The present essay grounds its argument in two, straightforward premises: (i) the
ethical principle of respect for human vulnerability is an indispensable measure of the
licitness of most, if not all, moral actions; and (ii) human organ trafficking violates the
ethical principle of respect for human vulnerability. Drawing from this syllogism, the aim
and proposal of this essay is to examine the principle of respect for human vulnerability
in the context of human organ trafficking with the intention of positing the argument that
human organ trafficking cannot, in most, if not all, cases, be morally justified insofar as it
violates the ethical principle of respect for human vulnerability. To secure the
justification of this thesis, the current essay moves in three parts. First, it will address the
ethical principle of respect for vulnerability, including a more specific analysis of the
ontology of vulnerability, its place in contemporary bioethics, and its application in the
context of organ trafficking. Second, it will sketch a general outline of the contemporary
practice of organ trafficking, including a specific analysis of its global status and the
trends and regulations with which it corresponds.
Third, it will address the case in favor of a regulated market in human organs,
including a specific analysis of the relationship it shares with both the personal freedom
and genuine – i.e., “full” – consent to commoditize the human body, as well as the
logistical plausibility of safeguards as institutional methods by which to combat
vulnerability. Finally, it will forward a persuasive argument, grounded in the analysis of
Parts 1-3 (delineated as Sections 2, 3, and 4, respectively, in the essay), against the
general practice of organ trafficking, highlighting the incongruity of bodily

21. Tazeen H. Jafar, “Organ Trafficking: Global Solutions for a Global Problem,” American
Journal of Kidney Diseases 54, no. 6 (December 2009): 1145-46.
22. Scheper-Hughes, “Rotten Trade,” 197.

commodification23 with social moral responsibility and personal integrity, as well as the
broader illicitness of a regulated approach to compensated donation and its inescapable
violation of the ethical principle of respect for human vulnerability.
Before proceeding, however, a note of clarification is in order. The purpose of this
essay is not to illuminate the general moral illicitness of organ trafficking. Insofar as the
practice relies explicitly on deception, coercion, and manipulation, that much is already
clear. Rather, against the backdrop of a growing scarcity of organs globally, the aim of
the current essay is to underscore the ethical principle of respect for vulnerability as the
linchpin of the practice’s refutation. Contemporary economic globalization,
simultaneously effecting an increasing amount of displaced persons around the world,24
suggests that revisiting the principle and its place as a safeguard in bioethical endeavors
and analysis pertaining to issues of global justice – such as is found in the present context
– is a task more timely than ever.
2. THE PRINCIPLE OF RESPECT FOR HUMAN VULNERABILITY
2.1 The Ontology of Vulnerability
The term “vulnerability,” derived from the Latin vulnus, meaning “wound,” might
best be understood in the current context as “the susceptibility of being wounded.”
Arising in the field of bioethics in the 1978 Belmont Report, its conceptual meaning has
today become nebulous to the extent that it is often considered to lack meaning and is
subsequently found to be of little practical use.25 In the Report, vulnerability is addressed
and mentioned in relation to both individuals and populations as a whole, in the sections
on “voluntariness,” and “the systematic assessment of risks and benefits,” respectively.
Of particular importance in the Report is the need for protection of vulnerable
populations, particularly in biomedical research endeavors. The Report singles out
particular populations – including “racial minorities, the economically disadvantaged, the
very sick, and the institutionalized,”26 – who should be protected against the possibility of
being included in research solely for the purpose of convenience.27
The ontological origins of the notion of vulnerability as present bioethical
discourse were first introduced in the sphere of human experimentation, as characteristic
23. See Mark Schweda and Silke Schicktanz, “The ‘Spare Parts Person’? Conceptions of the
Human Body and Their Implications for Public Attitudes toward Organ Donation Sale,” Philosophy,
Ethics, and Humanities in Medicine 4, no. 4 (2009): 1-10.
24. Scheper-Hughes, “Rotten Trade,” 197.
25. Agomoni Ganguli-Mitra and Nikola Biller-Andorno, “Vulnerability in Healthcare and
Research Ethics” in The SAGE Handbook of Health Care Ethics: Core and Emerging Issues, eds. Ruth
Chadwick, Henk ten Have, and Eric M. Meslin (Thousand Oaks, CA: SAGE Publications, 2011), 239-50;
see especially p. 240.
26. National Commission for the Protection of Human Subjects of Biomedical and Behavioral
Research, Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of
Research, http://ohsr.od.nih.gov/guidelines/belmont.html (accessed December 15, 2012).
27. Contemporarily, this explicitly extends to children, pregnant women, prisoners, and people
with intellectual and physical disabilities. See Ganguli-Mitra and Biller-Andorno, “Vulnerability in
Healthcare and Research Ethics,” 240.

of particular individuals and populations most susceptible to maltreatment and abuse and
who were typically the most poorly defended against historically.28 The designation of
population groups as vulnerable implies a positive duty to protect and defend them
against the possibility of being maltreated or, as the original Latin implies, “wounded.”
Since its birth, bioethics has attempted to justify this principle by underscoring the
vitality of the principle of respect for autonomy and the consequent mandate of informed
consent, which continues to grow increasingly inclusive and strict, for all persons making
moral decisions in the clinical context. The principle of respect for autonomy29 is not
merely the acknowledgement of the capacity of persons to possess worldviews, make
choices, and take actions based on idiosyncratic values; it also includes the effective
effort to create the conditions, personal and social alike, within which to act on such
worldviews, choices, and values.30
While neither the 1978 Belmont Report, nor the WHO’s 1996 Declaration of
Helsinki, nor the 2005 UNESCO Universal Declaration on Bioethics and Human Rights
includes a specific philosophical definition of what is meant by “vulnerability” or
“human vulnerability,” the best ontological understanding of the subject remains to be
found in the 1972 text of Emmanuel Levinas, titled Humanisme de L’autre Homme, or
“Humanism of the Other Man.” Levinas was the first to treat vulnerability as an
important philosophical theme. Levinas begins his analysis of vulnerability by
interpreting it as manifestation of “subjectivity.” For Levinas, the individual, subjective
self always proceeds “otherness.” Thus, when the subjective self is made manifest, it is
born into relationship with a preexistent other, which awaits its arrival. In this sense, the
self is inescapably dependent upon this other and, hence, is vulnerable.31 As Levinas
writes: “The Self, from head to feet, until the bone marrow, is vulnerability.”32
“Vulnerability” thus enters the philosophical scene as a state intrinsic to subjective
phenomenology and as the fundamental condition of humanity insofar as the possibility
of the self can exist only to the extent that it is in relationship with the other.33
Hans Jonas, in his 1979 work Das Prinzip Verantwortung, or “The Principle of
Responsibility,” adds to the philosophical understanding of the ontology of vulnerability.
First, Jonas identifies vulnerability as the “perishable characteristic of what exists.” As
such, vulnerability extends to all corners of nature and human experience, and thus
renders human persons ontologically vulnerable at their core. As the natural state of the
human condition, vulnerability is inerasably inherent to the finitude and fragility of
28. Hasan A. Khamash and Robert S. Gaston, “Transplant Tourism: A Modern Iteration of an
Ancient Problem,” Current Opinion in Organ Transplantation 13 (2008): 395-99.
29. For an astute and detailed analysis of the principle of respect for autonomy, see Tom L.
Beauchamp and James F. Childress, Principles of Biomedical Ethics, 6th ed. (New York: Oxford
University Press, 2009), 99-148.
30. Maria Patrão Neves, “Article 8: Respect for Human Vulnerability and Personal Integrity,” in
The UNESCO Universal Declaration on Bioethics and Human Rights: Background, Principles and
Application, eds. Henk A. J. M. ten Have and Michèle S. Jean (Paris: UNESCO Publishing, 2009), 156.
31. Patrão Neves, “Article 8: Respect for Human Vulnerability and Personal Integrity,” 157-58.
32. Emmanual Levinas, Humanisme de L’autre Homme (Paris: Fata Morgana, 1972), 104;
translated from French by Patrão Neves, “Article 8: Respect for Human Vulnerability and Personal
Integrity,” 158.
33. Patrão Neves, “Article 8,” 158.

human experience. Hence, it is unable to be eliminated or erased, and requires the care of
others as manifest in their solidarity with, and non-exploitation of, that vulnerable
condition. In this sense, vulnerability can be seen to constitute a major theme in bioethics
as well as a core principle to be respected. This point was iterated in the 1998 Barcelona
Declaration,34 counting the vulnerability among its four fundamental principles of joint
European policy related to ethics and law. As the Declaration describes it, vulnerability
is a twofold notion expressive of (i) finitude and fragility of human life, which (ii)
grounds the possibility to act morally for those who possess autonomy. Those most
deserving protection are persons whose autonomy, dignity, or integrity are threatened.35
2.2 The Principle and its Place in Contemporary Bioethics
The principle of respect for human vulnerability is both complex and confusing. It
therefore invites curiosity over whether the principle is ipso facto futile or useful,
particularly as applied in concrete biomedical circumstances. Growing attention to the
concept of vulnerability in health care as manifest in policy documents, medical research,
and the academic literature from which each are developed offers competing, and at times
contradictory, understandings of the principle, issuing a conflicting impression of the
place of the principle is contemporary bioethics. A first flawed approach is a much too
broad notion of principle. This is the case, for example, of the first serious attempt to
develop a normative justification and consolidation of the principle, launched by a group
of European scholars in 1995. The aim of the research initiative was to examine the
“great principles of bioethics and biolaw” with the help of continental European
philosophy and theology to develop a theoretical and principle-based framework that
could compete with the fourfold principled-approach of Georgetown University’s Tom
Beauchamp and James Childress. This alternative approach coupled one of Beauchamp
and Childress’ principles, namely, autonomy, with the principles of dignity, integrity, and
vulnerability.36
Of the four principles listed by the group, vulnerability is understood to be
ontologically prior to the others. This is due to its presumed ability to express the fragility
of the human populous more concretely than its complimentary principles. Hence,
vulnerability should be viewed an inherent aspect of human persons and not, as
mentioned above, something that might be done away with through scientific and
medical research. As such, it may be viewed as a principle that unites moral strangers,
bridging the gap and regulating ethical discourses within the global community. For these
reasons, the principle of respect for human vulnerability can be understood as a principle
that serves as the biopolitical nucleus of contemporary global welfare.37

34. Barcelona Declaration,
http://www.ethicslaw.dk/publication/THE%20BARCELONA%20Dec%20Enelsk.pdf#search=%22Barcelo
na%20Declaration%20Bioethics%22 (accessed December 15, 2012).
35. Patrão Neves, “Article 8,” 158.
36. Solbakk, “Vulnerability,” 229.
37. Solbakk, “Vulnerability,” 230.

However, this understanding of vulnerability continues to receive mixed reviews
with contemporary scholars. One critique, mentioned above, is the broadness of its scope,
rendering the principle too vague to provide clear and comprehensive moral guidance.
Another centers on the fact so many groups, particularly in the context of international
research, are now considered to be vulnerable that it seems to bankrupt its moral force.
On the other hand, even an overbroad understanding can be interpreted as too narrow to
be helpful, risking such attention to the minute details of specific groups as to ignore the
broader, basal needs of non-vulnerable participants in research. This last element also
runs the risk of proving a manifestation of stereotyping. Even if the broad needs of the
particularly vulnerable groups are met, that might be insufficient to meet the more
specific needs of the most vulnerable persons belonging to generally vulnerable groups.
The more imminent failure still of the European research initiative is the principlist
language with which it couples vulnerability, namely, autonomy, integrity and dignity.
Such language unavoidably fall victim to the “‘deontic and purports to represent moral
requirements rather than the anthropological hallmarks they really are.’”38
A second flawed approach is an intentionally narrow conception of vulnerability.
This is the approach, for example, reflected in both the Belmont Report and the
Declaration of Helsinki. This restrictive, minimalist, consent-based approach justifies
protection of vulnerable persons on the basis of their inability to provide free and
informed consent to participation in treatment. Such a conception, however, is too narrow
in terms of its actual ability to cover the entire enterprise of vulnerability in biomedical
research and clinical practice. For this among other reasons, the concepts of fairness,
harm, wrong, and power have been interjected to address complex situations within
which additional safeguards to protect vulnerable groups – such as those related to
consent and the upholding of other ethical standards – are required. In this sense,
vulnerability can be understood and identified as that likely occurrence of additional or
greater wrong than can otherwise be expected in a particular scenario.39
The question remains of how the principle of respect for human vulnerability
ought to best be applied in light of the aforementioned critiques. Within the field of
clinical medicine, the principle of respect for human vulnerability helps, if nothing else,
to reinforce the autonomous rights of individual patients. Simultaneously, it appeals to
the health profession generally by establishing a “symmetrical relationship” with patients
and forces individual health care organizations to protect persons even when they do not
issue a complaint. The needs and interests of vulnerable populations should therefore
never be underestimated, which means that the principle that commands respect for
vulnerable groups, both socially and internationally, exemplifies that the benefit of some
should not by secured through the exploitation of others. It also signifies that
improvements in the well-being of some will only render the rest – those who find
themselves excluded – more vulnerable still. Moreover, the principle also signifies a new
understanding of the human body and disease in that, in light of the principle, the body is
no longer an object but a subject inseparable from the human person with whom it
attaches. At the level of experimentation, it demands a new level of communication
38. Solbakk, “Vulnerability,” 230-31; quotation from p. 231.
39. Solbakk, “Vulnerability,” 231-34.

between patient and physician, forcing the latter to focus more on the person treated than
the corresponding illness. In short, then, the principle of respect for human vulnerability
commissions a new logic into moral reflection “which no longer implies the claim of
persons’ rights by the solicitude of obligations that are due to all. . . .”40
3. THE ENTERPRISE OF HUMAN ORGAN TRAFFICKING
3.1 Status Quaestionis
Countries that have voluntarily facilitated organ trafficking, such as Pakistan41
and the Philippines, do not release specific data related to the amount of foreign patients
that travel to these countries in hope of securing transplantable organs. According to one
report coming out of the Philippines, “a quota of foreign nationals was intended but there
has been no report of data to indicate that such a stipulation has been fulfilled.”42 Despite
its secretive nature and the frequent difficulties obtaining pertinent data, the extent of
organ trafficking has become vividly evident through visits by researchers and by reports
prepared for presentation at the WHO. According to data collected by the Sindh Institute
of Urology and Transplantation, at least 2,000 kidneys transplants have been performed
in Pakistan to “transplant tourists” participating in trafficking practices. One esteemed
nephrologist in Port of Spain Trinidad reported to have witnessed some 80 patients
traveling from Trinidad to Pakistan to purchase organs. In the Philippines, a February
2007 newspaper account reported that some 3,000 kidney sales had been transacted that
year, leading the WHO to hold a regional consultation in Manila to call attention to its
objection to trafficking and the rampant commercialism being practiced globally. The
Cebu Province of the Philippines is now reported to be seeking out new organ sale
endeavors to increasing commercial transplants in the Philippines.43
Egyptian transplant professionals have estimated that Egypt performs at least 500
kidney transplants annually, a majority of which are performed from commercial living
donors. One study reports that transplant tourists participating in trafficking have
underdone kidney transplantation with tsunami victims in Chennai, India. Meanwhile, at
the WHO regional consultation in Slovenia, a Moldovan representative reported the
request of Israeli physicians to bring tourism to their country. The request was ultimately
denied but, at current, there is no penalty for Israeli insurance companies who facilitate
transplants to occur beyond the country’s borders.44, 45 As many as twenty Israeli patients
may undergo kidney transplantation in the Philippines each month. The consequence for

40. Patrão Neves, “Article 8,” 162-63; quotation from p. 263.
41. For a superb analysis of state of organ trade in Pakistan, see Mozam et al., “Conversations
with Kidney Vendors in Pakistan: An Ethnographic Study,” The Hastings Center Report 39, no. 3 (2009):
29-44.
42. Budiani-Saberi and Delmonico, “Organ Trafficking and Transplant Tourism,” 926.
43. Budiani-Saberi and Delmonico, “Organ Trafficking and Transplant Tourism,” 926.
44. See Susanne Lundin, “Organ Economy: Organ Trafficking in Moldova and Israel,” Public
Understanding of Science 21, no. 2 (2012): 226-41.
45. See Leevan, “Comparative Treatment of Human Organ Trafficking,” 1-35.

Israel manifests itself in the lost expertise of Israeli transplant surgeons.46
At the Second Global Consultation of Human Transplantation at the WHO
headquarters in Geneva in 2007, one scholar47 assembled a sampling of the trafficking by
the analysis of medical databases such as Lexis/Nexis, MEDLINE, PubMed academic
journal articles, and Google searches that included media sources related to transplant
tourism. He found that some five to ten percent of kidney transplants performed annually
around the globe were the product of organ trafficking. The credibility of his estimate
was supported by the following data: at least 100 nationals from countries such as Saudi
Arabia (700 in 2005), Taiwan (450 in 2005), Malaysia (131 in 2004), and South Korea
(124 in the first eight months of 2004) went abroad to participate in transplant
commercialism. Additionally, approximately twenty nationals from countries including
Australia, Japan, Oman, Morocco, India, Canada, and the United States traveled as
tourists to participate in trafficking. More striking still is the observation of the data
coming out of China48 in the summer or 2007. In 2006, 11,000 transplanted were
performed from executed prisoners. Of the 11,000 organs, 8,000 were kidneys, 3,000
were livers, and 200 were hearts. The 8,000 kidney transplants in China in 2006 would
account for ten percent of the total number of transplants performed globally in
trafficking programs. China’s recently adopted Human Transplantation Act, which bans
commercialism, has reduced the number of transplant to foreign patients by fifty percent.
Nonetheless, the reduction in Chinese transplant activity has presumably been replaced
by an increase in Philippine organ trafficking.49
3.2 Trends and Regulations
With these statistics in mind, this essay now moves to consider the trending
medical effects and reactive regulations on the emerging worldwide population of live
kidney donors who travel to participate in tracking practices.50, 51, 52 In Pakistan, medical
follow-up data suggests that long-term outcomes for patients – if such patients are among
the select few who receive the novelty follow-up care – is very troubling. The majority of
donors in Pakistan – approximately ninety-three percent – who sold a kidney to repay a
debt reported that they remained unable to pay their debt and received no economic
improvement in their lives. Their objective in selling their organs for a profit proved,
therefore, practically useless, painful, and unfulfilling. Such a disturbing report is not
only a record of Pakistani experience but also serves as an indictment of the international
transplant community inasmuch as it drastically overlooks the vulnerable plight of the
46. Budiani-Saberi and Delmonico, “Organ Trafficking and Transplant Tourism,” 926-27.
47. See Shimazono, “The State of the International Organ Trade,” 995-62.
48. See Allan M. Concejero and Chao-Long Chen, “Ethical Perspectives on Living Donor
Transplantation in Asia,” Liver Transplantation 15 (2009): 1658-61.
49. Budiani-Saberi and Delmonico, “Organ Trafficking and Transplant Tourism,” 927.
50. For a more specific and comprehensive view of this issue, see Jafar, “Organ Trafficking,”
1145-57.
51. For another, more comprehensive vision of the scope of the issue, see Eytan Mor and Hagai
Boas, “Organ Trafficking: Scope and Ethics Dilemma,” Current Diabetes Reports 5 (2005): 294-99.
52. For a sociological perspective on the issue, see Miran Epstein, “Sociological and Ethical Issues
in Transplant Commercialism,” Current Opinion in Organ Transplantation 14 (2009): 134-39.

donor whose interests remain equally valid to that of the recipient. Moreover, research
out of Egypt, where it is prohibited to transplant organs from deceased donors, indicates
that seventy-eight percent of commercial living donors reported a significant
deterioration in their general health condition. This is likely the result of insufficient
medical donor screening for donation, examination of preexisting medical conditions, and
the labor-intensive conditions into which the donor often returns immediately following
surgery. Follow-up studies suggest that eighty-one percent of donors spent the money
received within five months after nephrectomy, most typically to pay off financial debts
rather than investing the money in socio-economic tools to improve quality of life.53
Studies from Pakistan and Egypt are consistent with findings in India, Iran, and
the Philippines that reveal deterioration in the health conditions of commercial living
donors. A long-term financial disadvantage is also evident following long-term
nephrectomy due to inability to generate an adequate income level prior to donation.
Common experience in these countries therefore suggest social rejection and regret about
participation in trafficking. Such reports are consistent with interviews with donors who
explain clearly and emphatically that a cash payment does not solve the vulnerable state
of destitution.54 Conversations with kidney vendors in Pakistan are the most revealing
regarding the manifold plights suffered following nephrectomy. One ethnographic study
includes the narratives and conversations of researchers and donors. Among the
numerous issues identified are those related to surgical pain, incision “prickling,” and
muscle spasms, which continued to recur in some individuals three years after surgical
scars had healed.55, 56
Other issues reported from the Pakistani experience suggest feelings of
inhumanity (surgical incision scarring left some feeling they were half the person they
once were), fear about the remaining kidney (including what will happen if the kidney
fails to thrive in the future), a sense of hopelessness (as many as fifty percent of those
interviewed experienced severe anxiety and profound sense of lost meaning in life),
feelings of regret (related to the despair that the act did not help their financial lot and
feelings of betrayal to the divine via participation in the exchange), and feelings toward
the medical profession and medical professionals, generally of curiosity over whether
individual patient’s lives were values as much as the next (the impetus of which includes
a lack of sympathy and general engagement by the medical staff). The conversations in
the study include many who would not recommend anyone to sell a kidney – for any
reason. When petitioned why the subjects had themselves participated, the most common
response was “extreme poverty.”57
Against this background, the imminent need for thoroughgoing regulation of
national organs allocation is clear. The question of what alternatives exist is therefore
53. Budiani-Saberi and Delmonico, “Organ Trafficking and Transplant Tourism,” 927-28.
54. Budiani-Saberi and Delmonico, “Organ Trafficking and Transplant Tourism,” 928.
55. Mozam et al., “Conversations with Kidney Vendors in Pakistan,” 33.
56. For other physiological complications related to participation in trafficking, see Shimazono,
“The State of the International Organ Trade,” 995-62.
57. Mozam et al., “Conversations with Kidney Vendors,” 33-37.

necessarily raised. While little regulation exists in the countries most culpable for
exacerbating the vulnerable plight of those who participate due to conditions of poverty,
this essay will here attempt to issue some reasonable suggestions for improvement.
Among them is that each country would do well to consider establishing a system of
deceased organ donation. At a WHO Regional Consultation on Developing Organ
Donation from deceased donors, held in Kuwait City in 2007, transplant professionals
from Bahrain, Iran, Jordan, Kuwait, Lebanon, Libya, Morocco, Oman, Pakistan, Qatar,
Saudi Arabia, Sudan, Syria, Tunisia, United Arab Emirates, and Yemen supported such
an expansion. Each opposed commercialism, trafficking, and transplant tourism,
including the use of brokers and medical professionals who advertise such services for
economic benefit. The Statement from Kuwait suggested that each country (i) develop a
legal framework and national self-sufficiency in transplantation, (ii) must have a
transparency of transplantation practices, (iii) should disallow their insurance companies
to supporting such illegal practices as organ trafficking and transplant tourism. In
addition to this list, countries would also do well hold pharmaceutical and insurance
companies accountable for their engagement in the process, imposing fees and
penalties.58
4. THE CASE IN FAVOR OF A REGULATED MARKET IN ORGANS
4.1 Personal Freedom and Genuine Consent to Commodification
A first argument in favor of a regulated market in organs grounds itself in the
refutation of organ donation for profit as an illicit means of treating the human body –
namely, treating its parts as commodities to be bought and sold. As the argument goes,
the effort to avoid recasting spare human body parts or hoarding scarce medical resources
is not a challenge idiosyncratic to financial transactions, and is not, therefore, a legitimate
objection to offering financial compensation to increase the occurrence of living organ
donation. Such a concern is one to be addressed under any system of organ procurement.
In this light, kidney donation, viewed as an altruistic gift, whether the product of
trafficking or not, is seen to be entirely illusory rhetoric insofar as it applies to actors in
the system rather than just the specific donor.59
Donors, surgeons, organ procurement agencies, and recipients each objectify
organs, treat them as convertible objects, and charge fees for access to organs. In other
words, a significant amount of money changes hands within the walls of hospitals. If this
is so, a regulated market in organs can be seen as no more harmful. Ongoing discussions
regarding the moral permissibility of financial compensation, or other valuable
incentives, do not concern whether human organs should be commoditized, but rather
who should receive valuable health care and who should bear the astronomical costs. In
this vein of thought, the very act of legally prohibiting financial compensation for
donation renders organs a highly constrained commodity, where donors are required to
58. Budiani-Saberi and Delmonico, “Organ Trafficking and Transplant Tourism,” 928.
59. Mark J. Cherry, “Embracing the Commodification of Human Organs: Transplantation and the
Freedom to Sell Body Parts,” Saint Louis University Journal of Health Law and Policy 2, vol. 2 (2009):
365-66.

part with their physical property without material compensation while others (including
physicians, hospitals, procurement agencies, and the like) benefit financially, in terms of
both quality and quantity of life, being able to successfully and healthily return to work, a
drastic reduction in medical bills, and the like.60
The awarding of college scholarships is used in one author’s61 argument to drive
home the aforementioned points. In this logic, castigating raw financial incentives for
kidney donation in favor of the more rhetorically acceptable college scholarship award –
because college scholarship incentives might be seen as a means by which to preserve
altruism (even though altruism in the current context is denounced as illusory and overly
rhetorical) – strikes this proponent as a manifestation of deceptive marketing. In fact, it
might be viewed as a policy that specifically designed to seduce healthy members of
society into parting ways with what is their very valuable property in the name of
altruism, within what is otherwise known to be a commercial transaction, thereby further
complicating what ought to be a transparent and honest medical process.62
The author finally suggests that even college educations – in absence of the
aforementioned scholarships – might licitly be purchased through compensation for
kidney donation, and that both federal and state governments may even be convinced to
treat the “purchase” as a non-taxable transfer of resources. However, regardless of this
hypothetical suggestion, the public has already discovered the commercialization of
human bodies. Moreover, the argument goes, financially compensating donors would
also significantly enhance the fairness than the current prohibition on payments. That
human organs might be transferred at a price of zero does not ipso facto reduce the
significance of their value to zero. Rather, it straightforwardly transfers the value of the
organ from donor to recipient. College scholarships are surely one type of compensation,
but prospective donors may welcome the opportunity to improve their financial status
even if they do not possess a desire to attend college, or to support another through
college. Failing to acknowledge that human organs are a valuable commodity that can be
shared at a price encourages the continuation of a dishonest society and public policy in
what is otherwise a very financially valuable commercial transaction.63
4.2 Institutional Safeguards as Combating Vulnerability
A second argument in favor of a regulated market in human organs grounds itself
in a vigorously regulated approach. In this line of thinking, a defensible market in
commercialized organs should minimally have the following four characteristics: (i) the
priority of safety of the vendor and the recipient; (ii) transparency regarding risks to the
vendor and recipient, and regarding institutional outcomes and follow-up care; (iii)
institutional integrity with regard to establishing guidelines that broadly reflect the
conditions under which a given institution will and will not participate in organ vending,
including a mechanism of mediating institutional financial conflicts of interest; and (iv)
60. Cherry, “Embracing the Commodification,” 366.
61. See Cherry, “Embracing the Commodification,” 359-78.
62. Cherry, “Embracing the Commodification,” 366.
63. Cherry, “Embracing the Commodification,” 366-67.

operation under a rule of law, providing an avenue of enforceable redress if contractual
obligations are violated.64
Regarding safety and transparency, one argument suggests that, along with moral
value, safety and transparency have market value. If it is true that the desperation of
vendors and recipients motivates them to overlook the manifold risks that accompany
participation in trafficking practices, an alternative without hazards might become
increasingly more appealing, and would therefore be more likely to be socially accepted.
In fact, the market value of safety itself would succeed where moral prohibition and legal
sanction may have previously failed in reducing the practice of trafficking. In this view,
one might correctly object that viewing safety and transparency merely as market values
actually opens up the possibility that safety might be compromised in exchange for a
reduction in cost for the recipient, or, conversely, an increase in compensation to the
vendor. However, when safety and transparency are also viewed as concrete moral
obligations on the part of transplant professionals, standards of proof regarding safety
become clearer and the burden of proof lies firmly within transplant centers to be
transparent regarding safe practices.65
Regarding institutional integrity, one author66 suggests that, because nothing
obligates vendors, donors, recipients, transplant professionals, or transplant centers to
participate in organ markets,67 by fashioning a policy on an institutional level, vendors,
donors, and recipients with compatible moral commitments can cooperate with one
another, and, unlike the current system, the rights of each can remain respected in full. A
regulated approach will also ensure better medical care, such as allocating kidneys based
on precise HLA-matching. Alternatively, in conjunction with willing transplant
organizations, some waiting-list recipients may choose to bargain with the state, offering
Medicare an opportunity, for example, to save the cost of lifetime dialysis welfare in
exchange for acting as a purchasing agent for a transplantable kidney and decades of
coverage for immuno-suppression medication. The more specific content of individual
institutional policy would be of less relevance than the more general requirement for
institutions to formulate policy that adequately articulate the moral commitments of the
institution’s members.68
Regarding rule of law, the author suggests that legislative oversight of an organ
market would ensure that standards of safety are met, ensure good-faith enforcement of
contracts between vendors and other entities, and serve to protect against fraudulent
behavior. In the context of the organ market, this argument suggests that the law should
play a twofold role. First, rule of law should have a productive function that facilitates
freely consented-to arrangements between individuals and individual institutions. Second,
64. Hippen, “In Defense of a Regulated Market,” 611-612.
65. Hippen, “In Defense of a Regulated Market,” 612-13.
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(2009): 586-605.
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rule of law should be so designed as to protect the contractual and personal rights of
vendors, donors, recipients, professionals, and institutions. The productive functions of
law might include provisions for a common market in which individuals can negotiate
terms, as well as opportunities for vendors to bargain with the State regarding value of
exchange rates. The protective functions include designing sample contracts that satisfy
the side-constraints of safety and transparency, offering mediation mechanisms by which
to resolve conflicts pertaining to financial inducements to increase vending through the
breaching of safe practices.69
5. THE CASE AGAINST HUMAN ORGAN TRAFFICKING
5.1 Against the Commodification of the Human Body
As is clear above, arguments favoring regulated sales of organs70 argue against
social science paternalism and on behalf of individual rights, bodily autonomy, and the
right to sell one’s organs, tissues, blood, or other body products71 continue to gain
currency in contemporary academic circles. Moreover, some have argued from a
pragmatic position that regulation rather than prohibition or moral condemnation is the
more appropriate response to a practice that is already widely established in numerous
parts of the world.72 What is needed, the argument goes, is rigorous oversight and the
adoption of donor bills or rights to inform and protect prospective organ sellers.73
However, the problem with markets generally is that they reduce everything – including
human beings, their labor, and their capacity to reproduce – to the status of commodities
that can be bought and sold, traded, and stolen.74 Nowhere is this more dramatically
visible than in the market for human organs and tissues.75
As this essay has attempted to underscore through the delineation of statistics,
trends, current regulations, and patient narratives, in the developing world, vulnerable
populations, particularly those most poor, cannot really “do without” their extra organs.
Transplant surgeons have disseminated an untested hypothesis of so-called “risk-free”
live donation in the absence of any published, longitudinal studies regarding the effects of
organ removal on the poor. Organs Watch, a medical human rights group affiliated with
the University of California, Berkeley, has found that living kidney donors from slums,
inner cities, or prisons face extraordinary threats to their health and personal security
through violence, accidents, and infectious diseases, which can all too often easily
69. Hippen, “In Defense of a Regulated Market,” 613-14.
70. See Cherry, “Embracing the Commodification,” 359-78.
71. For a fine introduction to the boundaries of personhood, equity, and community in
biomedicine, see Patricia A. Marshall, “Introduction: Organ Transplantation – Defining the Boundaries of
Personhood, Equity, and Community,” Theoretical Medicine 17 (1996): v-viii.
72. See Hippen, “In Defense of a Regulated Market,” 593-626.
73. Nancy Scheper-Hughes, “The Global Traffic in Human Organs,” Current Anthropology 41,
no. 2 (2000): 197.
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75. Nancy Scheper-Hughes, “The Ends of the Body: Commodity Fetishism and the Global Traffic
in Organs,” SAIS Review, vol. XXII, no. 1 (Winter-Spring 2002): 62.

compromise their remaining kidney. As the use of live kidney donors has moved from the
industrialized West, where it typically takes place among relatives who are themselves
highly privileged, to areas of risk in the developing world,76 transplant surgeons have
become complicit in the needless suffering a hidden and vulnerable population.77
In all these transactions, the integrity of the body, so far as it can be known, is
radically transformed. The integration of the body and its parts as naturally given is
exchanged for a divisible body in which individual organs and tissues can be detached,
isolated, and, worse still, sold. This points to the demise of classical humanism, holism,
and the personal responsibility with which each corresponds, eventuating in an “ethics of
pieces” – part histories, part truths, and now divisible bodies in which detached organs
emerge as market economies, as “fetishized objects of desire and consumption.”78
Contemporary bioethical arguments concerning the right to sell an organ or other body
part are based on Western notions of contract and individual, autonomous “choice.” But
the social and economic contexts in which organ trafficking is practiced makes the
“choice” to sell a kidney anything but “free” and “autonomous.” The idea of consent is
deeply problematic when one has no other option to sustain one’s family than to sell an
organ to do so.79
Assigning a market price to body parts – even a potentially fair one – unavoidably
exploits the desperation of the poor, suddenly transforming suffering into what seems like
opportunity. Moreover, asking law to negotiate a fair price for a living human kidney
flies in the face of everything contract theory stands for. When concepts like individual
agency and autonomy are invoked to defend the “right” to sell organs, ethicists might
rightly suggest that certain “living” things are not alienable or proper candidates for
commodification. Further, the surgical removal of non-renewable organs is an act in
which medical professionals, given their ethical standards, should not be asked to
participate. In this sense, even the argument for regulation proves to be out of touch with
the social and medical realities operating in many parts of the world, and especially in
developing nations. Statistics alone suggest that tools developed to monitor organ
harvesting and distribution through trafficking practices is often dysfunctional, corrupt, or
compromised by the power of organ markets80 and the exemption of organ brokers and
maverick surgeons willing to violate the first premise of classic biomedical ethics: first,
do no harm.81
Clarity is hence needed amidst the tension between donors and recipients,
between physicians and patients, between individuals and the State, and between the
illegal and the merely unethical about whose values and which notions of the body and
embodiment are being represented. Transplant surgeons must pay more attention to
where organs come from and the manner in which they are procured. There must be firm
76. Rashad S. Barsoum, “Trends in Unrelated-Donor Kidney Transplantation in the Developing
World,” Pediatric Nephrology 23 (2008): 1925-29.
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assurances that donations everywhere is voluntary and uncoerced, especially among
vulnerable populations. Finally, the risks and benefits of organ transplantation ought to be
more equally distributed within nations, ethnic groups, genders, and social classes. The
division of the world into organ buyers and sellers is a medical, social, and moral tragedy
of immense and as yet unrecognized proportion.82
5.2 Against the Regulated Approach to Compensated Donation
As mentioned above, some have argued83 from a pragmatic position that
regulation rather than prohibition or moral condemnation is the more appropriate
response to a practice that is already widely established in numerous parts of the world.84
However, several problems remain for this view of organ markets. The first concerns the
ambiguity of “safe practices” and conflicts of interest. The limitations and controversies
in the current literature on the evaluation of long-term outcomes should be of critical
concern in the moral evaluation of the licitness of a regulated market in organs. In the
context of abuses of organ trafficking, the burden of proof lies within transplant
institutions to prove that organ donors have been properly evaluated and that vendors can
safely vend. Though donors are routinely notified of the risks as they arise, the unique
position of the donor role can conspire both potential donors and transplant professionals
to judge that the benefits outweigh the burdens that do not rise to the level of absolute
surety. This problem is only complicated by the dynamics of the organ market itself,
which may influence a number of vendors and transplant professions – even acting in
good faith – to modify judgments about which risks are acceptable and which are not.
Moreover, financial incentives are likely to motivate either vendors or professions to act
in bad faith by deliberately setting aside data indicating greater risk. Hence, a slippery
slope to the exploitation of the vulnerable becomes vividly clear.85
A second problem regards vendors from nations that do not afford protections
which fulfill side-constraints, such as transparency. As is clear by now, organ trafficking
operates outside the law of most countries. The success of a legalized organ market
governed by side-constraints therefore already rests on fragile trust. It requires trust in
transplant professionals and institutions operating according to a moral and professional
commitment to place the safety of the vendor first, and in accord with rules of law that
protect the contractual rights of vendors that is credibly enforced. When some vendors,
even apart from the pressures of organ brokers of the severe constraints of poverty, might
be prepared to bypass the standards of safety, transplant professionals have a moral
obligation not to participate in the vendor relationship that violates the side-constraint of
safe practices. It is possible that some vendors, frustrated at being turned away by
transplant centers that take the side-constraints seriously, will turn to organ brokers and
organ trafficking. This much would only contribute to the abuse of already vulnerable
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populations.86
A third problem concerns limits on the fungibility of organs as a commodity. As
the previous subsection states, viewing organs as “things” that can be permissibly bought
and sold raises the question of whether entities other than the buyer and seller can
legitimately claim property right over an organ. In the case of deceased donor organs, this
question is partially addressed by the model of a market whereby the organ of a living
person is purchased in advance, and the property right is transferred upon death to the
possessor of an “organ future.” This is by no means an idle concern. Hospitals in
numerous developing countries have conspired to dispose of transplantable organs from
potential deceased donors to avoid damaging the underground trade in organs from live
vendors. Other commentators in India have observed that the presence of organ
trafficking ultimately dilutes the political will to institute a robust program for deceased
donor procurement. This is conceptually identical to the owner of an organ future
destroying an organ to manipulate the value of competing financial interests. Even if the
absence of such a robust program is clandestine, the lack of a program that results in an
increase in demand for organs from living vendors is a system that benefits organ
trafficking, which in turn inescapably preys upon the poor.87
A final problem explicitly involves the selling of organs as commodities. Since
the vendor is selling an organ while alive, an organ, viewed as a commodity, could also
be viewed as a valuable asset by third parties who have other financial relationships with
vendors. As noted above, vendors may choose to sell their organs for a wide variety of
reasons, including, most commonly, the repayment of accumulated debts. If this practice
is permissible, and absent alternative means of payment, the question of whether a
creditor may require the sale of an organ – either for living vendors of after death – for
the purpose of debt repayment is raised. If an organ, viewed as property, is part of the
estate of the living or deceased vendor, this question tests the limits of a vendor’s “right
to vend” and a forbearance right. If it is permissible to allow vendors to sell their organs
and use the exchange to benefit their own ends, it seems arbitrary to prohibit third parties
from insisting that vendors requisitely fulfill a financial obligation by selling a kidney.
This much proves to be yet another slippery slope to exploitation of the most vulnerable
in society.88
6. CONCLUSION
The principle of respect for human vulnerability, including the ontology of
vulnerability, its place in contemporary bioethics, and its application in the context of
organ trafficking; the contemporary enterprise of human organ trafficking, including its
global status and the trends and regulations with which it corresponds; and the case in
favor of a regulated market in organs, including the relationship it shares with both
personal freedom and genuine – i.e., “full” – consent to commoditize the human body, as
well as the logistical plausibility of safeguards as institutional methods by which to
86. Hippen, “A Regulated Market,” 616.
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combat vulnerability, are but three issues of principle significance in the debate over the
moral licitness of human organ trafficking. Drawing from the twofold premises that (i)
the ethical principle of respect for human vulnerability is an indispensable measure of the
licitness of most, if not all, moral actions; and (ii) human organ trafficking violates the
ethical principle of respect for human vulnerability, the aim and proposal of this essay
has been to examine the principle of respect for human vulnerability in the context of
human organ trafficking with the intention of positing the argument that human organ
trafficking cannot, in most, if not all, cases, be morally justified insofar as it violates the
ethical principle of respect for human vulnerability. To this syllogistic end, it has been
successful.
The implications here are significant. To be sure, the reality of organ trafficking
and the abuse of vulnerable populations through participation in compensated donation is
a genuine and growing fear. But rather than allowing it to terminate human progress, may
it instead serve to remind that while the benefits of transplant capacities are important,
how and how far they are utilized is more important still. On a conclusory note, it is
worth underscoring again that the principal thesis pursued herein has been an
inexhaustive attempt to nail down an argument in favor of the general moral prohibition
of participation in organ trafficking – or for any participation in a compensated donation
program whereby vulnerable populations are unavoidably targeted. Hence, exceptions
may exist. Still, the impetus to continue the exploration of transplant techniques and
related therapies therapy to assist individuals to donate and receive organs uncoerced and
free of manipulation should remain a priority of contemporary biomedical research.
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